Clinical trials continue to be a driving force in ophthalmology, propelling the development of innovative treatments and ...
The U.S. Food and Drug Administration and the European Medicines Agency jointly issued principles for safe and responsible ...
During a live event, Omid Hamid, MD, discussed the logistics and multidisciplinary process of using tumor-infiltrating ...
The lifecycle of a medical device is under renewed regulatory and commercial scrutiny. Although lifetime expectations are not ...
AI prioritizes clinical trials by identifying unmet medical needs, optimizing resource allocation, and focusing on conditions ...
Clinical Trials Arena on MSN
FDA and EMA release collaborative AI framework for drug development
The FDA and EMA's joint guidance was created to ensure the pharmaceutical industry employs best practices when using AI in ...
Therapy often stops when symptoms ease, not when deeper problems are understood. What gets missed when treatment fixes ...
Presenters shared their personal highlights of attending ASCO GI 2026. The 2026 American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Cancers Symposium showcased not only transformative ...
HPV status, particularly combined p16 and HPV positivity, is vital for patient selection in de-escalation strategies for ...
Although AI can help general practictioners and patients, if used critically, the human touch at the heart of good general ...
Top of the list is that AIs must be human-centric by design and align with ethical values. They must be developed using a ...
Increases circulation: “Though this isn’t a long-term benefit, it is one of the more immediate ones,” notes Dr. Garshick.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback